Skip to content
DataLookout
Menu

Dementia clinical trials

Get alerts when Dementia trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-08

What changed in the last 30 days

133 trials changed in the last 30 days: 3 stopped, 60 with notable changes, 70 with minor changes only.

  1. Minor: 11 trials marked Unknown by the registry's verification sweep Changed Registry verification sweep11 trials
    1. Minor: SANDY · Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation Fondazione Don Carlo Gnocchi ETSNot specified NCT06875739
    2. Minor: DROM-test · Decision Support Tool for Assessing the Ability to Decide on Returning Home · Cognitive Impairments Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting Assistance Publique - Hôpitaux de ParisNot applicable NCT06669559
    3. Minor: CONSTELLATIONS Living Lab: Improving the Care Transitions · Neurocognitive Disorders Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Laval UniversityNot applicable NCT06608589
    4. Minor: RCTCogRehab · Multidimensional Rehabilitation Programs for Cognitive Impairment in Comorbid Outpatients: a Randomized Controlled Trial Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Istituti Clinici Scientifici Maugeri SpANot applicable NCT05954741
    5. Minor: SIM-2 · Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Ruijin HospitalNot applicable NCT05887674
    6. Minor: RJNB-AD · Ruijin Neurobank of Alzheimer's Disease and Dementia Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Ruijin HospitalNot specified NCT05623124
    7. Minor: AMUSED · Adherence by Music to Exercise in Dementia: Group Therapy Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting Hasselt UniversityNot applicable NCT05603533
    8. Minor: Psychometric Evaluation · Brain Damage During Neuroinflammation Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation Neuromed IRCCSNot specified NCT05450237
    9. Minor: REMINDER · Validation of the REMINDER Dementia Risk Reduction Program Changed Registry marked status Unknown (sponsor has not verified the record since May 2024); last known: Recruiting University of CoimbraNot applicable NCT05296980
    10. Minor: Longitudinal Study Examining At-Home tDCS Changed Registry marked status Unknown (sponsor has not verified the record since Aug 2024); last known: Recruiting Lady Davis InstituteNot applicable NCT04524338
    11. Minor: Warmth and Transcutaneous Electrical Nerve Stimulation (TENS) in Improving Cognitive Functions · Dementia Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting The Hong Kong Polytechnic UniversityNot applicable NCT03614962
  2. Notable: Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease Primary endpoint(s) modified The Methodist Hospital Research InstitutePhase 1/2 NCT07651319
  3. Notable: Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease Primary endpoint(s) modified The University of Hong KongNot applicable NCT07779863
  4. Notable: NAB-IT · Nabilone for Agitation Blinded Intervention Trial Primary and study completion pushed from Apr 2027 to Dec 2027 Sunnybrook Health Sciences CentrePhase 3 NCT04516057
  5. Notable: TARBELA-AD · Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease Recruitment opened Hoffmann-La RochePhase 2 NCT07781657
  6. Notable: BIOMARK-PS · Molecular Biomarkers for Differentiating Parkinsonian Syndromes Enrolling by invitation only International Institute of Molecular and Cell Biology in WarsawNot specified NCT07604883
  7. Notable: SIRENS · Technology-Based Intervention Pilot Testing Recruitment opened Weill Medical College of Cornell UniversityNot applicable NCT07146581
  8. Notable: LEAD · Locus-coeruleus Function in Normal Elderly and AD Risk Results posted: Nov 6, 2026 NYU Langone HealthNot applicable NCT04403165
  9. Minor: PRIM-A · Prediction of Effectiveness of rTMS Application in Alzheimer's Patients Trial completed Istanbul Medipol University HospitalNot applicable NCT05977088
  10. Minor: PrevenTRON · Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease Trial sites expanded: 34 → 72 locations Hoffmann-La RochePhase 3 NCT07717411
  11. Minor: TREMHANCE · SAR448851 · Early Alzheimer's Disease Trial sites expanded: 20 → 32 locations SanofiPhase 2 NCT07688213
  12. Notable: Flutemetamol F 18 Injection Formulation Comparison Recruitment opened GE HealthcarePhase 2 NCT07873463
  13. Notable: Smartphone Application Intervention in Community Settings: A Pretest-Posttest Pilot Study Recruitment opened The University of Texas Medical Branch, GalvestonNot applicable NCT07313540
  14. Notable: Autonomy · JNJ-63733657 · Early Alzheimer's Disease Results posted: Nov 5, 2026 Janssen Research & Development, LLCPhase 2 NCT04619420
  15. Minor: Health enSuite Caregivers: an App-based Treatment for Distressed Caregivers · Moderate Dementia Trial status changed: Not Yet Recruiting → Active, Not Recruiting IWK Health CentreNot applicable NCT04944420
  16. Minor: ACP-204 · Alzheimer's Disease Psychosis Trial sites expanded: 152 → 155 locations ACADIA Pharmaceuticals Inc.Phase 2/3 NCT06159673
  17. Minor: Master Protocol Studying Multiple Amyloid-Targeting Therapies in Healthy Participants and · Alzheimer's Disease Trial sites expanded: 16 → 19 locations Eli Lilly and CompanyPhase 1 NCT07787169
  18. Minor: Prediction and Prevention of Postoperative Mortality and Morbidity Start date pushed from Oct 2026 to Nov 2026 University of PittsburghNot applicable NCT06042413
  19. Notable: VOCALE LBD · Online Peer Support for Caregivers · Lewy Body Dementia Recruitment opened University of WashingtonNot applicable NCT07637097
  20. Notable: Role of Gait Analysis in Different Type of Dementia Primary endpoint(s) modified Assiut UniversityNot specified NCT06713070
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-11-05 NCT07918638 Prospective Research on Identification of Dementia in Early Stages (P.R.I.D.E) Don Mottola Medical Center new
2026-11-03 NCT07912710 China HEalthy Aging and Dementia Study (HEAD) Fudan University new
2026-10-30 NCT07907042 Effects of Doll Therapy on Apathy and Activities of Daily Living Initiation Deficits in… Xinyu ZHANG new
2026-10-30 NCT07905872 Feasibility of Community Occupational Therapy for Dementia (COT-D) University of Vic - Central University of Catalonia new
2026-10-29 NCT07905352 A Phase 2 Clinical Study of Simenafil Hydrochloride Tablets in the Treatment of… Vigonvita Life Sciences new Phase 2
2026-10-23 NCT07892651 MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT) Axiom Bioregistry new
2026-10-22 NCT07890207 Human-LLM Conversations as a Digital Signature of Cognitive Performance in Adults Technion, Israel Institute of Technology new
2026-10-22 NCT07889349 A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection… Beijing Suncadia Pharmaceuticals Co., Ltd new Phase 1
2026-10-02 NCT07856043 [11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection Fraction Stony Brook University new Phase 1
2026-10-02 NCT07854327 Restoring Cervical Lymphatic Drainage in Alzheimer's Disease University of Siena new

Active trials by phase

Early Phase 1
21
Phase 1
76
Phase 1/2
50
Phase 2
138
Phase 2/3
18
Phase 3
70
Phase 4
32
Not charted: 1,109 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Get alerts when Dementia trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free

Narrower conditions

Active trials